TOP PHARM CO.,LIMITED
|Place of Origin:||China|
|Brand Name:||Top Pharm|
|Minimum Order Quantity:||10g|
|Packaging Details:||As your requirments|
|Delivery Time:||3-6 working days|
|Payment Terms:||T/T, Western Union, MoneyGram,bitcoin|
|Supply Ability:||bulk stock|
|Appearance:||White Loose Lyophilized Powder.||Purity:||99%|
CAS 120511-73-1 Anastrozole Powder,
99% Purity Anastrozole Powder,
C17H19N5 Anastrozole Powder
Product Name:Anastrozole (arimidex)
CAS : 120511-73-1
Molecular formula: C17H19N5
Molecular weight: 293.37
Appearance: an off-white color crystalline powder
ARIMIDEX (anastrozole) tablets for oral administration contain 1 mg of anastrozole, a non-steroidal aromatase inhibitor. It is chemically described as 1,3-Benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl). Its molecular formula is C17H19N5 and its structural formula is:
Anastrozole is an off-white powder with a molecular weight of 293.4. Anastrozole has moderate aqueous solubility (0.5 mg/mL at 25°C); solubility is independent of pH in the physiological range. Anastrozole is freely soluble in methanol, acetone, ethanol, and tetrahydrofuran, and very soluble in acetonitrile.
Each tablet contains as inactive ingredients: lactose, magnesium stearate, hydroxypropylmethylcellulose, polyethylene glycol, povidone, sodium starch glycolate, and titanium dioxide.
ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.
ARIMIDEX is indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer.
ARIMIDEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to ARIMIDEX.
Dosages of Anastrozole:
Dosage Forms and Strengths
Dosage Considerations – Should be Given as Follows:
Pediatric: Use not recommended
Effects of Drug Abuse
Pregnancy and Lactation
Contact Person: Anne